D-0034-2025 Class III Ongoing

Recalled by Denison Pharmaceuticals, LLC — Lincoln, RI

FDA drug recall D-0034-2025 was initiated by Denison Pharmaceuticals, LLC on Sep 25, 2024 and is designated Class III. Reason for recall: Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles. The recall status is ongoing. Affected quantity: 105,048 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 13, 2024
Initiation Date
Sep 25, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
105,048 bottles

Product description

Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged in 4 oz bottles further packaged in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code# 850015736018

Reason for recall

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Distribution pattern

Product was distributed to two accounts that may have distributed the product further to the Retail Level.

Code information

Lot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0034-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0034-2025. Report a data issue: hello@regdatalab.com.